This poor outcome was also evident for the rare STAG2-mutant cases that were not diagnosed as AML-MR because of competing classifying mutations (e.g., NPM1 and/or CEPBA, Supplementary Fig. 10A, B). The gene discussed is NPM1; the disease is acute myeloid leukemia.